Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05137093 · ClinicalTrials.gov registry record
Scratching Validation Study
A clinical trial, sponsored by Philips Clinical & Medical Affairs Global.
- Completed
- Registry status
- 27
- Enrollment target
NCT05137093: Completed study, sponsored by Philips Clinical & Medical Affairs Global.
NCT05137093 is a clinical trial that has completed, run by Philips Clinical & Medical Affairs Global. The registered enrollment target is 27 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05137093 has completed, sponsored by Philips Clinical & Medical Affairs Global.
- COMPLETED
- Registry status
- 27 participants
- Enrollment target
Study Summary
Single center, analyst-blinded, study comparing the scratching events identified via an actigraphy scoring algorithm versus manual scoring of an overnight video recording, undertaken in a sample of 40 adult patients with atopic dermatitis and controls.
Primary Outcome
Assessment of the performance of the scratching algorithm as detected by actigraphy compared to infra red video monitoring.
Interventions
- DEVICE Actigraphy Device
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 27 participants |
| Start Date | 2021-12-10 |
| Est. Completion | 2023-02-01 |
What the finished NCT05137093 record still lists
NCT05137093 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 27 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Actigraphy Device is the first listed.
NCT05137093 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05137093 about?
NCT05137093 is a clinical study titled "Scratching Validation Study". Single center, analyst-blinded, study comparing the scratching events identified via an actigraphy scoring algorithm versus manual scoring of an overnight video recording, undertaken in a sample of 40 adult patients with atopic dermatitis and controls.
What is the current status of trial NCT05137093?
This trial is currently completed. The enrollment target is 27 participants. The study started on 2021-12-10. Estimated completion is 2023-02-01.
What interventions are being tested in trial NCT05137093?
The interventions under investigation include: Actigraphy Device (DEVICE).
Who is sponsoring clinical trial NCT05137093?
This trial is sponsored by Philips Clinical & Medical Affairs Global, which has 45 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00912041 · 27 participants · NA
BrainGate2: Feasibility Study of an Intracortical Neural Interface System for Persons With Tetraplegia
- NCT02847559 · 27 participants · Phase 2
Optune Delivered Electric Field Therapy and Bevacizumab in Treating Patients With Recurrent or Progressive Grade 2 or 3 Meningioma
- NCT03380195 · 27 participants · NA
Effects of Watermelon Juice on Heart Rate Recovery and Post-exercise Muscle Soreness
- NCT03384238 · 27 participants · Phase 1
Panitumumab-IRDye800 in Patients With Pancreatic Cancer Undergoing Surgery
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI